Jingyan Xie
- Reproductive Medicine top 10%
- Endometriosis Research and Treatment 5
- Ovarian cancer diagnosis and treatment 2
-
- MicroRNA in disease regulation 3
-
- Reproductive System and Pregnancy 6
-
- Endometrial and Cervical Cancer Treatments 3
-
- Cancer Immunotherapy and Biomarkers 2
-
- Extracellular vesicles in disease 2
-
- Pelvic floor disorders treatments 2
- Co-authors
- Shuli ZhaoJing ZhouJingyun ZhangQingling WangMengna LiuYujuan LiYunzhong NieQiong‐Yu Mi
- Journals
- Scientific Reports (1 paper)Frontiers in Immunology (1 paper)Fertility and Sterility (1 paper)
- Partner nations
- China
In The Last Decade
Jingyan Xie
18 papers receiving 360 citations
Peers
Comparison fields: 5 of 58
- Reproductive Medicine 60
- Cancer Research 101
- Immunology 137
- Obstetrics and Gynecology 29
- Oncology 93
Countries citing papers authored by Jingyan Xie
This map shows the geographic impact of Jingyan Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyan Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyan Xie more than expected).
Fields of papers citing papers by Jingyan Xie
This network shows the impact of papers produced by Jingyan Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyan Xie. The network helps show where Jingyan Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingyan Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 10 | |
| 6 | 2019 | 110 | |
| 7 | 2019 | 29 | |
| 8 | 2017 | 21 | |
| 9 | [Elevated levels of dendritic cell-correlated miRNAs in ascites and sera of patients with ovarian cancer]. | 2015 | 4 |
| 10 | Midkine as a potential diagnostic marker in epithelial ovarian cancer for cisplatin/paclitaxel combination clinical therapy. | 2015 | 21 |
| 11 | 2014 | 21 | |
| 12 | 2014 | 96 | |
| 13 | [Detection of lymphocyte subsets in the peripheral blood of patients with malignant ovarian tumors]. | 2014 | 1 |
| 14 | Relativity of polymorphism of the interleukin-10 gene and endometriosis | 2010 | 1 |
| 15 | Association of estrogen receptor alpha gene polymorphisms with endometriosis | 2010 | 2 |
| 16 | [Study on the relationship between polymorphism sites of IL-10 and the susceptibility of endometriosis]. | 2010 | 1 |
| 17 | 2010 | 8 | |
| 18 | 2008 | 31 | |
| 19 | [Changes of collagen content in uterine ligaments of perimenopausal women with relaxation of pelvic supports]. | 2008 | 2 |
About Jingyan Xie
Jingyan Xie is a scholar working on Reproductive Medicine, Immunology and Obstetrics and Gynecology, having authored 19 papers that have together received 367 indexed citations. Recurring topics across this work include Reproductive System and Pregnancy (6 papers), Endometriosis Research and Treatment (5 papers), Endometrial and Cervical Cancer Treatments (3 papers), MicroRNA in disease regulation (3 papers), Extracellular vesicles in disease (2 papers), Pelvic floor disorders treatments (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Reproductive Medicine (60 citations), Cancer Research (101 citations) and Immunology (137 citations). Jingyan Xie has collaborated with scholars based in China. Frequent co-authors include Shuli Zhao, Jing Zhou, Jingyun Zhang, Qingling Wang, Mengna Liu, Yujuan Li, Yunzhong Nie, Qiong‐Yu Mi, Runling Zhang and Yujuan Li. Their work appears in journals such as Scientific Reports, Frontiers in Immunology and Fertility and Sterility.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.